FDA Seeks Nominations for Members to Serve on the Tobacco Products Scientific Advisory Committee

August 15, 2016

FDA Seeks Nominations for Individuals to Serve on Tobacco Products Scientific Advisory Committee

On Monday, August 15th, FDA issued a notice requesting nominations for a nonvoting member to serve on the Tobacco Products Scientific Advisory Committee to represent the interests of tobacco growers.  In addition, FDA is also seeking a nominee to act as an alternate to this representative.

FDA states that any organization interested in participating in the selection of this nonvoting member should notify the Agency in writing by September 14, 2016.  The nominee may be “self-nominated or nominated by an organization to serve as a nonvoting industry representative.”

Tobacco Products Scientific Advisory Committee

The role of the Tobacco Products Scientific Advisory Committee is to guide the FDA Commissioner.  “The Committee reviews and evaluates safety, dependence, and health issues relating to tobacco products and provides appropriate advice, information, and recommendations to the Commissioner.”

Application Procedure

FDA’s notice states that nominations will only be accepted for positions that are vacant as of the publication date of the Agency’s notice.  Contact information, current curriculum vitae (CV), and the name of the committee of interest should be sent to the FDA Advisory Committee Membership Nomination Portal by September 14, 2016.

In addition, FDA states that it “seeks to include the views of women, and men, members of all racial and ethnic groups, and individuals with and without disabilities on its advisory committees and, therefore encourages nominations of appropriately qualified candidates from these groups.”




Generic Drugs Agency Alerts

August 15, 2016

Senator: FDA’s Backlog of ANDAs is Causing “Harm” to Consumers

On September 28, 2015, Sen. David Vitter (R-LA) sent a letter to FDA’s Acting Commissioner, Stephen Ostroff, MD, in which he stated various concerns regarding an extensive backlog of Abbreviated New...

Read More
Good Clinical Practice Agency Alerts

August 15, 2016

FDA to Modify Informed Consent Rules, Seeks Feedback

On Tuesday, November 13th, FDA proposed to add an exception to its informed consent requirements for minimal risk FDA-regulated clinical investigations. Under the Agency’s current regulations,...

Read More
Agency Alerts

August 15, 2016

FDA Takes Steps to Ensure Patients are Informed of Safety Risks Associated with Essure

Additional information on FDA's review of Essure is available in our previous FDA News article entitled "Coming Soon: FDA Safety Review of Essure" On Monday, February 29th, FDA announced that it will...

Read More